Why the study?
Early risk stratification of left-sided infective endocarditis remains critical for informing in-hospital prognostic assessment, motivating the development and internal validation of a prognostic nomogram integrating the Naples Prognostic Score and LVEF.
Population
312 patients with left-sided infective endocarditis admitted between 2020 and 2024
Comparison
Prognostic model integrating Naples Prognostic Score and LVEF for predicting in-hospital adverse outcomes
Design
Single-centre retrospective cohort study with internal bootstrap validation
Follow-up
In-hospital
Answers are grounded in this paper and cite their sources.
Nomogram integrating NPS and LVEF may aid in-hospital risk stratification in left-sided IE; leaves open prospective validation before clinical adoption.
Background Early risk stratification of left-sided infective endocarditis (IE), a severe valvular heart disease, remains critical for informing in-hospital prognostic assessment. This study sought to develop and internally validate a prognostic nomogram integrating the Naples Prognostic Score (NPS) and left ventricular ejection fraction (LVEF) to predict in-hospital adverse outcomes among patients with left-sided IE. Methods This single-centre cohort study enrolled 312 patients with left-sided IE admitted between 2020 and 2024. Independent predictors were identified using LASSO regression followed by multivariable logistic regression. Prognostic performance was evaluated via receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). A nomogram was constructed and internally validated via bootstrap resampling. Clinical utility was assessed using decision curve analysis (DCA) and clinical impact curve (CIC). Results In-hospital composite adverse outcomes occurred in 68 patients (21.8%). Higher admission NPS (per 1-point increment, OR = 3.01) and reduced LVEF (OR = 0.84) were independent prognostic factors. The combined NPS–LVEF model yielded improved discriminative performance (AUC = 0.839) and significant reclassification benefit (continuous NRI = 0.658, IDI = 0.061, both P < 0.001). The nomogram showed good concordance (C-index = 0.839), acceptable calibration, and favourable net clinical benefit in internal validation analyses. Conclusions The dual-dimensional NPS–LVEF model integrating systemic immuno-nutritional status and cardiac function improves early risk stratification performance for left-sided IE. This nomogram, built using routine admission variables, enables individualised prognostic estimation for research purposes. Given the single-centre retrospective design and internal validation only, external multicentre validation is required prior to any potential real-world clinical translation. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: